The National Human Genome Research Institute defines genomic medicine as “an emerging medical discipline that involves using genomic information about an individual as part of their clinical care (e.g., for diagnostic or therapeutic decision-making) and the health outcomes and policy implications of that clinical use.”
Scientists at The Wistar Institute in collaboration with Roswell Park Cancer Institute found a significant association between a rare genetic variant of the p53 gene present in African American women and their risk of developing breast cancer in premenopausal age.
Scientists have discovered the first evidence of genes that cause Macular Telangiectasia type 2 (MacTel), a degenerative eye disease which leads to blindness and is currently incurable and untreatable.
A study by Weill Cornell Medicine-Qatar (WCM-Q) researchers has revealed many previously unknown links between genetic variations and a series of debilitating conditions, including Alzheimer’s disease, heart disease, autoimmune disorders and cancer.
This activity is an Accredited Group Learning Activity (Category 1) as defined by the Qatar Council for Healthcare Practitioners – Accreditation Department and is approved for a maximum of 12.25 hours.
Doha, 16 February 2015: The importance of regional medical research collaboration was the focus of the ‘Biobanking in the Context of Personalised Healthcare’ conference, hosted by Qatar Biobank, a member of Qatar Foundation for Education, Science and Community Development, in Doha last week.
Doha, 02 February 2015: Qatar Biobank, a member of Qatar Foundation for Education, Science and Community Development, is set to host the nation’s first conference that will explore the development of Qatar’s healthcare and medical research community this month.
Doha, 28 January 2015: Qatar Biobank, a member of Qatar Foundation for Education, Science and Community Development (QF), has released the findings of its two year operational pilot phase, which reveal that 76 per cent of male and 70 per cent of female participants, from a sample of 1,200 are either overweight or obese. It also reveals that 52.7 per cent of the male participants and 31.7 per cent of female participants recorded pre-hypertensive (normal-high blood pressure levels) or hypertensive.
11 June 2014 Doha: Qatar’s National Genome Committee is hosting the country’s first Human Genomics Symposium which began yesterday at the Qatar National Convention Centre in Doha.
You are being invited to take part in Qatar Biobank, Qatar’s long-term medical health initiative for Qatar’s population. To help you decide whether to contribute, here is some information on Qatar Biobank and what taking part involves.
Qatar Biobank will make it possible for scientists to conduct research to address some of the greatest health challenges facing Qatar and the region, including cardiovascular disease, obesity, diabetes, and cancer.